Skip to main content
. 2016 Jun 13;10(6):962–968. doi: 10.5009/gnl15426

Fig. 2.

Fig. 2

The change in hepatocellular carcinoma (HCC) risk after antiviral therapy according to three treatment criteria. NHI, National Health Insurance; EASL, European Association for the Study of the Liver.